TGFB1 and cancer: Our findings are in agreement with Dooley and ten Dijke (2012) who stated that TGF-β is recognized as a major profibrogenic cytokine included in hepatic fibrosis and its signaling is involved in all disease progression stages, from hepatic injury which include inflammation and fibrosis, to cirrhosis and cancer.